MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202641124753 A) filed by Vellore Institute Of Technology on October 19, 2026, for Use Of 4,8-Diphenyl-[1,3]dioxolo[4,5-D]azepine-5,7-Dione For Targeting Wild-Type And -Mutant Akt1.
Inventors include Devi Rajeswari V; and Harinivas M.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The present invention relates to an integrated computational method for identifying and characterising Sargassum-derived marine natural-product metabolites as potential AKT1-targeting agents. A library of Sargassum-associated metabolites is progressively screened based on ADME and drug-likeness characteristics, predicted ...